The IR team

We encourage all shareholders and investment professionals to contact us, should you have any questions or requests concerning Novozymes.
MRSN

Martin Riise 
Head of Investor Relations

Mobile: +45 3077 0738
mrsn@novozymes.com



MRSN

Klaus Sindahl 
Investor Relations, NA

Mobile: +45 5363 0134
ksdh@novozymes.com






2015 in brief

Organic sales growth

4%

EBIT

27.7%

ROIC

25.9%

Annual report 2015

In 2015, the world market for industrial enzymes expanded by 10% to an estimated DKK 25 billion, driven mainly by currencies. Novozymes remained the market leader with a 48% share of the market.

Date Event Announcement
2016.01.19
Group financial statement Q4 2015 EN DK
2015.10.21
Group financial statement Q3 2015 EN DK
2015.08.05
Group financial statement Q2 2015 EN DK
2015.04.22
Group financial statement Q1 2015 EN DK

Key figures

Novozymes annual and quarterly key figures, five-year summary and long-term targets.

Corporate governance

Shareholder meetings, the board of directors and management team and the statutory report on corporate governance.

Meet us

An overview of investor events, roadshows, conference calls and shareholder meetings.

Financial information at your fingertips

Download Novozymes' Investor Relations app for iOS and Android.

appstore    googleplay

apple-iphones